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Brother of CDO (BOC) is a cell surface receptor that derives its name from the structurally related protein,
cell adhesion molecule-related/down-regulated by oncogenes (CDO, sometimes CDON). High levels of
BOC mRNA and protein expression have been described in embryonic tissues with active cell prolifer-
ation and ongoing cellular differentiation1,2. A microarray-based screen of RNA isolated from 11 different
adult equine tissues unexpectedly identiﬁed BOC as having an expression pattern restricted to articular
cartilage. The objective of this study was to further investigate BOC expression in adult articular cartilage
relative to other tissues. Both RT-qPCR and mRNA sequencing conﬁrmed the microarray data. Steady
state BOC mRNA levels in articular cartilage were substantially higher than in the other adult tissues
tested, neonatal tendon, placenta, and whole embryo. The expression of BOC displayed a pattern of tissue
speciﬁcity comparable to well established cartilage matrix protein biomarkers. BOC mRNA levels in
articular cartilage increased with age, but were rapidly down-regulated when chondrocytes were
enzymatically isolated from the cartilage matrix and expanded in monolayer culture. Relative expression
patterns of CDO were broadly similar, but displayed lower fold change differences. A functional role in
articular cartilage that involves Hedgehog signaling is suggested by the known binding afﬁnity of BOC for
all three Hedgehog ligands. These data also extend BOC and CDO biology to a post-mitotic and highly
differentiated cell type within a mature tissue.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Methods, results, and discussion
Equine tissue samples were collected under approved Institu-
tional Animal Care and Use Committee protocols. Total RNA was
isolated using variations of acid guanidinium thiocyanate/phenol/
chloroform extraction with alcohol and salt precipitations, pro-
cessed with a ﬁnal RNeasy silica gel column puriﬁcation (Qiagen
Inc., Valencia, CA, #74104), ethanol precipitated, and solubilized in
nuclease-free water (Ambion, #AM9937). Quantitative and quali-
tative parameters of the RNA preparations were assessed using
a NanoDrop ND-1000 spectrophotometer and a Bioanalyzer 2100
(Agilent Technologies, Eukaryotic Total RNA Nano Series II).
Samples had 260/280 ratios of 1.7e2.0, 260/230 ratios of 1.8e2.1,
and an Agilent RNA integrity number (RIN) of 8.0.
Microarray-based transcriptional proﬁling was used to compare
adult full thickness articular cartilage to 10 other equine tissuesJ.N. MacLeod, Department of
, KY 40546, USA.
).
s Research Society International. Pusing a 9413-element equine-speciﬁc cDNA microarray as previ-
ously described3. Median ﬂuorescent intensities were adjusted for
background and Lowess-normalized for each individual slide.
Quantile regression was used as previously described4 to estimate
the conditional quantile of the M and A log ratios given the
observed average log intensity. Brieﬂy, a nonparametric approach
was used to reveal the relationship between percentiles of M and A,
where M is log2 (R/G) and A is 0.5 log2 (RG) with R representing
expression in articular cartilage and G representing expression in
the comparative tissue. The quantile regression was ﬁt using a B-
splinewith ﬁve ﬁxed nodes. The ﬁrst, ﬁfth, tenth, twentieth, ﬁftieth,
eightieth, ninetieth, ninety-ﬁfth, and ninety-ninth conditional
quantiles were estimated. For each observed gene intensity in
a given tissue comparison, the normal quantile was used as the
cartilage-speciﬁcity in place of the corresponding estimated
regression quantile. Microarray data are available at the NCBI Gene
Expression Omnibus (GEO)5,6 under series accession number
GSE23862.
The microarray screen identiﬁed 37 genes with expression in
articular cartilage above the 95th conditional quantile in all 10 of
the cartilage/tissue comparisons analyzed (Z-scores 1.96 in all 10ublished by Elsevier Ltd. All rights reserved.
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ciated with chondrocytes or cartilage including well-established
cartilage biomarkers such as hyaluronan and proteoglycan link
protein 1 (HAPLN1), cartilage oligomeric matrix protein (COMP),
aggrecan core protein (ACAN), procollagen type II alpha 1 (COL2A1),
and procollagen type XI alpha 1 (COL11A1)4. The remaining 24
genes (65%) had no or very limited functional annotation that could
be related directly to cartilage. One of these 24 genes was BOC
(microarray cDNA probe corresponding to the EST in Genbank
accession number CX600450.1). Across eight of the cartilage/tissue
comparisons, BOC expression was in the upper 99th percentile of
cartilage-speciﬁcity (Z-scores2.57) and BOC expression remained
in the 95th quantile for the other two tissues (Supplementary
Table I). CDO was not identiﬁed as having a cartilage-restricted
pattern of expression at this same stringency threshold by the
microarray screen. Previous published surveys of BOC and CDO
expression in adult tissues had found low to undetectable levels,
but neither of these sample sets included articular cartilage1,7.
To conﬁrm the microarray data and quantitate steady state BOC
mRNA levels across tissues, a real-time RT-qPCR assay was per-
formed with consideration of MIQE guidelines8. Brieﬂy, 500 ng of
total RNA were reverse-transcribed (RT) into cDNA using
commercial reagents and oligo-dT primers (Promega Corp., Madi-
son, WI, #A3500). RT-qPCR was performed on a 7900HT Fast Real-
Time PCR System (Applied Biosystems, Foster City, CA), using
TaqMan Gene Expression Master Mix, and primer-probe sets
designed with consideration of exon junctions and conserved
regions of equine, human, and mouse sequence (http://www.
ensembl.org/Equus_caballus/index.html; Applied Biosystems,
Assays-by-Design; Supplementary Table II). After measuring
ampliﬁcation efﬁciencies by LinRegPCR9 and selecting the two
reference genes that displayed the greatest stability by the geNorm
reference gene application10, mRNA levels of BOC were found to be
substantially higher in articular cartilage compared to all of the
other tissues evaluated (Fig. 1A, Supplementary Table III). Speciﬁ-
cally, steady state BOC mRNA levels were 5.7-fold higher in adult
articular cartilage relative to the 34-day whole embryo sample,
which had the second highest level of BOC mRNA among theFig. 1. Detection of BOC mRNA and protein localization. (A) Tissue distribution of BOC and C
triplicate. All data were normalized to the reference genes PGK1 and RPLPO and are presente
(34D Embryo¼ 34 day post conception whole embryo) (B) Detection of BOC protein in art
articular cartilage. 100 magniﬁcation. Scale bar¼ 100 microns.evaluated tissues. Across the 13 other tissue comparisons, relative
BOC transcript levels were approximately 19e1122-fold higher in
adult articular cartilage. Interestingly, this included 19.7- and 36.6-
fold increases relative to nasal and costal cartilaginous tissues,
respectively. Expression patterns for CDO were broadly similar, but
with lower fold change differences, ranging from approximately 2-
to 36-fold.
Relative expression was also measured by mRNA sequencing
(RNA-seq) as described by Coleman et al, 201011. RNA-seq, con-
ducted using articular cartilage from a different horse, quantiﬁed
BOC expression at 5.8-fold higher than the 34-day fetus, a value
highly concordant with the qPCR data. Differences of approxi-
mately 30e55-fold were observed for cerebellum, placenta, and
testes, which is somewhat lower than the RT-qPCR ratios. This
likely reﬂects direct quantiﬁcation of tag density that extends the
dynamic range of RNA-seq especially for samples with very low
levels of expression12. CDO relative expression ratios for the same
tissue comparisons using RNA-seq were 2.1, 7.4, 11.0, and 16.8,
respectively (Supplementary Table IV).
Protein localization was evaluated by immunohistochemistry
with two independent BOC-speciﬁc antibodies, one monoclonal
(R&D Systems Inc., Minneapolis, MN, #MAB20361) and one poly-
clonal (Imgenex, San Diego, CA, #IMG-30652). Immunostaining
was performed using automated (Leica Bond-max Fully Auto-
mated IHC and ISH System, Leica Microsystems Inc., Bannockburn,
IL) and manual (AvidineBiotin Complex Immunohistochemistry
Staining System, Santa Cruz Biotechnology, Santa Cruz, California, #
sc-2023) protocols. Sections processed manually were treated with
3% hydrogen peroxide, blocked in 1.5% serum, and incubated with
a primary antibody overnight at 4C. Following staining, the
sections were counterstained with Gill No.3 hematoxylin (Sigma,
#HS316). Articular chondrocytes in both pellet cultures (Fig. 1B)
and cartilage tissue (Fig.1C) displayed positive staining for BOC that
appeared to localize to cell membranes. Lymph node
(Supplementary Fig. 1A) and other non-cartilaginous tissues (liver
and small intestine, data not shown) were negative, as were
experimental controls that deleted either the primary or secondary
antibodies (Supplementary Fig. 1B and C).DO expression. Results are presented as mean values for each tissue (n¼ 1) analyzed in
d relative to 34-day whole embryo mRNA expression levels of BOC and CDO, separately.
icular chondrocytes in pellet culture. (C) Detection of BOC protein in chondrocytes in
Table I
Effect of chondrocyte dedifferentiation on BOC and CDO expression. Steady state
mRNA expression levels of BOC and CDO signiﬁcantly decline when articular carti-
lage (n¼ 4 horses) is compared to chondrocytes expanded in monolayer cell culture
(n¼ 6 horses). RT-qPCR expression data were normalized by gene (BOC or CDO) to
the reference genes, EIF2B2 and UBP1. Data represent the mean the standard error
of the mean
Articular chondrocytes expression BOC mRNA expression CDO mRNA
Articular cartilage 2.6707 0.7643 1.3648 0.4783
P-0, Day 0 0.1063 0.0408* 0.4686 0.2459y
P-0, Day 7 0.2155þ 0.0433* 0.6776 0.2086y
P-1, Day 14 0.3061 0.0871* 0.2193 0.0756y
P-2, Day 21 0.2796 0.1140* 0.2936 0.1137y
P-3, Day 28 0.1940 0.0428* 0.2569 0.0692y
P¼ passage number.
* P< 0.001, BOC mRNA expression comparison of chondrocytes in cartilage to
chondrocytes at each stage in culture.
y P< 0.001, CDO mRNA expression comparison of chondrocytes in cartilage to
chondrocytes at each stage in culture.
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(0e10 days of age) to adult horses (4e5 years of age) demonstrated
a 2.4-fold increase in steady state BOC mRNA with maturation
(P¼ 0.013, Supplementary Table V). No age-dependent difference
was observed for CDO (P¼ 0.633). This experiment also enabled
inter-animal variation in articular cartilage BOC and CDO expres-
sion to be assessed. For the seven foals and six adult horses, the
pooled standard error of the difference for BOC was 0.09 and for
CDO was 0.06. To determine how tightly linked BOC and CDO
expression are to the differentiated phenotype of articular chon-
drocytes, articular cartilage samples (n¼ 4 horses) were compared
to primary chondrocyte cultures (n¼ 6 horses) over 28 days and
three passages. The Mixed Procedure for SAS was used to log
transform data and evaluate signiﬁcant differences in mRNA
expression. Steady state BOC and CDO mRNA levels dropped
signiﬁcantly (P< 0.001) even by completion of the chondrocyte
isolation protocol (day 0, passage 0), and remained substantially
lower than articular cartilage throughout the duration of the
monolayer culture period (Table I). As expected, levels of mRNA
transcripts encoding procollagen type II alpha 1 (COL2A1) and
ACAN were signiﬁcantly down regulated, while procollagen type I
alpha 2 (COL1A2) mRNA increased in the same samples (data not
shown).
In published reports, BOC expression in embryonic tissues has
generated functional annotation associated with developmental
cellular differentiation and axon guidance1,2,13. Results of the
current experiments are the ﬁrst to identify high BOC mRNA levels
in mature articular chondrocytes, a nondividing and differentiated
population of cells. The apparent tissue-restricted pattern of this
expression raises interesting questions regarding the functional
role(s) of BOC and CDO in articular cartilage. During embryonic
development, BOC functions as a cell-surface receptor for
important signaling pathways including Hedgehog and p38 a/b
MAPK13,14. Indeed, BOC has been shown to speciﬁcally bind all
three Hedgehog ligands with high afﬁnity15. When the results of
the current study are viewed in the context of known functional
roles of BOC and CDO, it seems plausible that BOC facilitates
articular chondrocyte speciﬁcity for conserved signaling pathways
and contributes to receptor complex formation.Role of the funding source
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